Nu Skin Enterprises, Inc. (NYSE:NUS) Short Interest Up 44.4% in June

Nu Skin Enterprises, Inc. (NYSE:NUS) was the target of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 2,440,000 shares, an increase of 44.4% from the June 15th total of 1,690,000 shares. Currently, 5.0% of the shares of the stock are sold short. Based on an average trading volume of 881,300 shares, the short-interest ratio is presently 2.8 days.

NUS has been the subject of a number of analyst reports. Tigress Financial reiterated a “buy” rating on shares of Nu Skin Enterprises in a research report on Friday, May 29th. Deutsche Bank upped their price target on shares of Nu Skin Enterprises from $28.00 to $35.00 and gave the stock a “hold” rating in a research report on Thursday, May 7th. Jefferies Financial Group upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating and upped their price target for the stock from $42.00 to $50.00 in a research report on Thursday. Stifel Nicolaus upped their price target on shares of Nu Skin Enterprises from $35.00 to $36.00 and gave the stock a “hold” rating in a research report on Thursday, June 11th. Finally, Citigroup upped their price target on shares of Nu Skin Enterprises from $29.00 to $41.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company. Nu Skin Enterprises presently has a consensus rating of “Hold” and a consensus target price of $45.00.

NYSE NUS traded up $9.57 during trading hours on Friday, hitting $48.02. 4,810,630 shares of the company’s stock traded hands, compared to its average volume of 891,118. Nu Skin Enterprises has a 52-week low of $12.31 and a 52-week high of $48.61. The company has a market capitalization of $2.49 billion, a PE ratio of 17.79, a PEG ratio of 12.53 and a beta of 1.18. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.74 and a quick ratio of 1.12. The firm’s 50-day moving average is $37.19 and its 200-day moving average is $32.22.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.11. Nu Skin Enterprises had a net margin of 6.49% and a return on equity of 17.91%. The company had revenue of $518.03 million during the quarter, compared to analysts’ expectations of $477.01 million. During the same quarter in the prior year, the company earned $0.77 EPS. Nu Skin Enterprises’s revenue was down 16.9% compared to the same quarter last year. Equities research analysts predict that Nu Skin Enterprises will post 2.27 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 10th. Investors of record on Friday, May 29th were paid a dividend of $0.375 per share. The ex-dividend date was Thursday, May 28th. This represents a $1.50 annualized dividend and a yield of 3.12%. Nu Skin Enterprises’s dividend payout ratio is presently 48.39%.

In other Nu Skin Enterprises news, insider Joseph Y. Chang sold 34,970 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $40.01, for a total value of $1,399,149.70. Following the completion of the transaction, the insider now owns 37,882 shares in the company, valued at $1,515,658.82. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 3.40% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Advisor Group Holdings Inc. purchased a new stake in shares of Nu Skin Enterprises in the 1st quarter valued at approximately $68,000. Meeder Asset Management Inc. grew its stake in shares of Nu Skin Enterprises by 39.1% in the 4th quarter. Meeder Asset Management Inc. now owns 3,339 shares of the company’s stock valued at $137,000 after buying an additional 938 shares during the period. Ladenburg Thalmann Financial Services Inc. grew its stake in shares of Nu Skin Enterprises by 200.3% in the 4th quarter. Ladenburg Thalmann Financial Services Inc. now owns 4,379 shares of the company’s stock valued at $180,000 after buying an additional 2,921 shares during the period. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Nu Skin Enterprises in the 4th quarter valued at approximately $204,000. Finally, CIBC World Markets Inc. purchased a new stake in shares of Nu Skin Enterprises in the 4th quarter valued at approximately $219,000. 74.39% of the stock is owned by institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Featured Story: Systematic Risk

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.